Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
390
-
Total 13F shares, excl. options
-
29.1M
-
Shares change
-
+215K
-
Total reported value, excl. options
-
$8.53B
-
Value change
-
+$83.8M
-
Put/Call ratio
-
1.02
-
Number of buys
-
184
-
Number of sells
-
-181
-
Price
-
$293.33
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q4 2020
452 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q4 2020.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 390 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.1M shares
of 33M outstanding shares and own 88.22% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.98M shares), VANGUARD GROUP INC (3.03M shares), WELLINGTON MANAGEMENT GROUP LLP (2.45M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.56M shares), JPMORGAN CHASE & CO (1.14M shares), Invesco Ltd. (943K shares), STATE STREET CORP (755K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (751K shares), RIVERBRIDGE PARTNERS LLC (739K shares), and WELLS FARGO & COMPANY/MN (643K shares).
This table shows the top 390 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.